Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01035Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE203.152.3 (+1.15 %)
PREV CLOSE () 200.85
OPEN PRICE () 203.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1911
TODAY'S LOW / HIGH ()201.70 203.65
52 WK LOW / HIGH ()194 301.8
NSE202.452.02 (+1.01 %)
PREV CLOSE() 200.43
OPEN PRICE () 201.15
BID PRICE (QTY) 202.45 (85)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 25154
TODAY'S LOW / HIGH() 200.58 204.26
52 WK LOW / HIGH ()192.85 301.65
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Harsha Raghavan - Chairman Manish Gupta - Managing Director

Registered Office :

Address : Innov8 3rd Floor, Plot No. 211,Okhla Phase-3, ,
New Delhi,
Delhi-110020

Phone : 011-46181100 / 46109900

Website : www.jagsonpal.com

Registrar's Details : MCS Ltd
179-180, DSIDC Shed, 3,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE
NEWS
18Nov Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that the Nomination and Remunerat..
05Nov Jagsonpal Pharmaceuticals informs abo
Pursuant to the provisions of Regulation 47 of SEBI (Listing Obligations..
07Oct Jagsonpal Pharmaceuticals informs abou
Jagsonpal Pharmaceuticals has informed that consequent to the appointmen..
26Sep Jagsonpal Pharmaceuticals informs abou
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and..
20Sep Jagsonpal Pharmaceuticals informs abou
Pursuant to Regulation 30 and other applicable provisions of the SEBI (L..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit125.74553.61
Gross Profit 168.1 698.59
Operating Profit 194.61592.61
Net Sales 744.652687.16
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Shareholding Pattern
PROMOTERS 67.54%
NON-INSTITUTION 30.25%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI